bestseller

Cavion LLC - Pharmaceuticals & Healthcare - Deals And Alliances Profile

Summary Cavion LLC (Cavion), formerly Tau Therapeutics, LLC. is a clinical stage biopharmaceutical company that develops drugs. The company develops therapies for the treatment of oncologic and neurologic diseases. Its product under

Region : 03143502 | Price: 2900 | Report ID: 03143502
Summary

Cavion LLC (Cavion), formerly Tau Therapeutics, LLC. is a clinical stage biopharmaceutical company that develops drugs. The company develops therapies for the treatment of oncologic and neurologic diseases. Its product under clinical development includes non-addictive, non-opioid T-type calcium channel and mibefradil dihydrochloride. The company invents therapies for the treatment of solid tumors, cancer and neurologic diseases. Cavion provides chemotherapy, radiation, and targeted therapies for solid tumor cancers. It develops therapies for neurologic afflictions such as Parkinsonís disease, epilepsy, and Angelman syndrome. The company operates through research and development facility. Cavion is headquartered in Charlottesville, Virginia, the US.

Cavion LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companyís (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the companyís operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cavion LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cavion LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cavion LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cavion LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cavion LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cavion LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Cavion Raises USD26 Million in Series A Financing 10
Tau Therapeutics Raises US$9.3 Million In Venture Financing 11
Tau Therapeutics Raises US$3 Million In Venture Financing 11
Tau Therapeutics Raises USD4.2 Million in Private Financing 12
Merger 13
Tau Therapeutics Merges with Xdynia 13
Debt Offering 13
Cavion Raises USD5 Million in Private Placement of Notes 13
Cavion LLC - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

 

Research Methodology

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.